<DOC>
	<DOCNO>NCT00584896</DOCNO>
	<brief_summary>The purpose study determine use PB127 cardiac ultrasound assist diagnosis exclusion coronary artery disease .</brief_summary>
	<brief_title>Safety Efficacy Study PB127 Ultrasound Contrast Agent Diagnosis Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . 18 year old old able provide write informed consent ; 2 . All subject must schedule undergone SPECT within 28 day prior follow Study Day 1 3 . Subjects low/low pretest probability coronary artery disease must consent participate extension trial 127014A 4 . Subjects low/low pretest probability coronary artery disease must current diagnosis obstructive CAD angiogram prior MI 5 . Subjects low/low pretest probability coronary artery disease current diagnosis obstructive CAD angiogram prior MI may enrol Stratum 2 6 . Subjects intermediate high pretest probability coronary artery disease must schedule coronary angiography within 28 day follow Study Day 1 7 . Sinus rhythm time study procedure 8 . Adequate visualization myocardial segment 9 . Appropriate candidate stress test accord ACC/AHA Guidelines Exercise Testing 1 . Women pregnant lactate 2 . Known hypersensitivity know contraindication : 1 . Dipyridamole 2 . Ultrasound contrast agent ( include PB127 excipients ) 3 . Blood , blood product , albumin , egg , protein 3 . Use caffeine xanthine containing product within 24 hour prior Study Day 1 4 . Previous exposure PB127 Ultrasound Contrast Agent 5 . Major surgery within 7 day prior Study Day 1 ( require general anesthesia and/or overnight stay ) 6 . Heart transplant history CABG 7 . Known hemodynamically significant symptomatic righttoleft shunt ( include shunt associate prior TIAs stroke ) 8 . Recent history sustain ventricular tachycardia 9 . Pacemaker defibrillator 10 . Unstable cardiac status 1 . Unstable angina grade CCS Class IV severity ( physical activity cause limit symptom ; symptom may present rest patient prior exertional angina ) ongoing symptom and/or ongoing infusion intravenous nitroglycerin 2 . Decompensated heart failure 3 . Seconddegree great heart block , sick sinus syndrome 4 . Frequent ( &gt; 60/hour ) symptomatic ventricular ectopics baseline 5 . Hypertension ( SBP &gt; 200 and/or DBP &gt; 110 mmHg two consecutive reading within one hour PB127 MPE ) 6 . Hypotension ( SBP &lt; 90 mmHg ) 7 . Severe aortic stenosis ( &gt; 40 mmHg mean gradient &lt; 0.6 cm2/m2 valve area index ) 8 . Pulmonary edema within 7 day prior Study Day 1 9 . Resting oxygen saturation le 90 % room air 11 . Myocardial infarction cerebral vascular accident / transient ischemic attack within 28 day prior Study Day 1 12 . Chronic Obstructive Pulmonary Disease ( COPD ) bronchospastic airway disease , opinion Investigator , significant enough contraindicate dipyridamole 13 . Known history severe pulmonary hypertension characterize estimate pulmonary artery systolic pressure &gt; 50 mmHg 14 . Liver disease characterize one follow 1 . Current jaundice 2 . Elevated bilirubin &gt; upper limit normal 3 . Currently elevate hepatic enzyme &gt; 2X upper limit normal 4 . Current previous hepatic viral infection ( include hepatitis A ) 5 . Chronic hepatitis 15 . Medical condition circumstance would significantly decrease chance obtain reliable data achieve study objective ( i.e. , drug dependence , psychiatric disorder , dementia , associate illness ) ; extenuate circumstance medical condition make unlikely patient complete clinical trial follow evaluation ; reason expect poor compliance clinical investigator 's instruction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>heart disease</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>echocardiogram</keyword>
	<keyword>ultrasound</keyword>
	<keyword>angiogram</keyword>
	<keyword>SPECT</keyword>
	<keyword>chest pain</keyword>
	<keyword>perfusion</keyword>
</DOC>